A ARROWHEAD PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Dec 2024)
What this means for you
Registered since 17 Jul 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86983891
- Registration number
- 5520059
- Mark type
- Word mark
- Filed
- 25 Mar 2016
- Published for opposition
- 06 Sept 2016
- Registered
- 17 Jul 2018
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development
Owner
- ARROWHEAD PHARMACEUTICALS, INC., Pasadena, CA, US
- ARROWHEAD PHARMACEUTICALS, INC., PASADENA, CA, US
- ARROWHEAD PHARMACEUTICALS, INC., PASADENA, CA, US
- Arrowhead Research Corporation, Pasadena, CA, US
Prosecution history
- 04 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 17 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Jan 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Jan 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 12 Jun 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Jun 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 May 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 01 May 2018 — USE AMENDMENT FILED
- 10 May 2018 — DIVISIONAL PROCESSING COMPLETE
- 01 May 2018 — DIVISIONAL REQUEST RECEIVED
- 07 May 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL